News

Switzerland, 21 July, 2016 – ESMO, the leading European professional organisation for medical oncology, has announced that the ESMO 2018 Annual Congress…

London, July 2016 – “It is becoming increasingly clear that neurological disorders, such as stroke and dementia but to name a few, are projected to rise…

EVIDENCE from a study carried out in the USA shows that arthroscopic hip surgery might not always be a suitable option for people with osteoarthritis…

DISCOVERY of a new function in a widely used anti-inflammatory drug could offer new insight into the divergent efficacies of different medications which…

London, 14 July, 2016 – The International Congress on Neuromuscular Diseases (ICND) just drew to an end in Toronto. Among the many questions addressed…

Janssen Pharmaceuticals, Inc. announced that the U.S. FDA has granted Priority Review designation for the New Drug Application for a 500mg chewable tablet formulation of mebendazole

Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field…

NEW, less invasive therapy has been discovered for the treatment of prostate cancer. The therapy provides a middle ground for men who have previously had…